Alphabet, a holding company, and private equity firms Silver Lake Partners, Ontario Teachers' Pension Plan Board and Temasek Holdings, led a $700m funding round in Verily Life Sciences, a developer of tools and devices to collect and analyze health data to research and manage diseases. The capital will be used to support rapid expansion of some of Verily’s leading commercial businesses. The company will also progress several of its life sciences programs across surgery, pathology and immunology. "We’re humbled and excited about the opportunity to expand the scope and rapidly scale our products and services. With this new round of funding from our largest investors, they are strengthening their commitment to help expedite our original vision,” Andrew Conrad, Verily CEO and Founder.